Articles

Found results: 16338

Various

Will new drugs become cheaper?

Currently, the drug development cycle from the early stages to commercialization can cost billions of dollars. The agreement concluded by the largest pharmaceutical companies can reduce the cost of research and, accordingly, the prices of drugs.

02.10.2012
Other life sciences

Help elderly T-helpers!

Researchers from Stanford have found out what prevents T-helpers from performing their functions in older people.

01.10.2012
Biomedicine

Express diagnostics: imitating nature

Mimicking natural recognition mechanisms, bioengineers from the USA and Italy have developed inexpensive medical diagnostic tests that can give results within a few minutes.

01.10.2012
Prolonging youth

Rejuvenate aged muscles

An international team of scientists has managed to discover for the first time the key factor responsible for the aging of muscle tissue and disable it in mice with the help of existing drugs.

01.10.2012
Various

Elderly drivers: trust, but check

According to researchers, older drivers in the UK get into accidents less often than young people. Perhaps because at the age of 70 they are required to retake the law exam, and then repeat this procedure every three years.

01.10.2012
Prolonging youth

Pills for a healthy old age

The fact that many elderly people are trying to improve their appearance and generally slow down or even reverse the aging process has become very relevant for attending physicians.

27.09.2012
Biomedicine

A crutch for a disabled sperm

British biologists were able to fertilize female eggs using defective spermatozoa by adding the protein PLCz, which is missing in sperm, necessary for the fusion of male and female germ cells, to a test tube with cells

27.09.2012
Biomedicine

microRNAs will protect the heart from hypertrophy

Scientists hope that miR-212 and miR-132 micro-RNA inhibitors, alone or in combination with other therapeutic techniques, can become a completely new approach to the treatment and prevention of heart failure in humans.

27.09.2012
New in Gerontology

Positive results of progeria treatment were obtained for the first time

Lonafarnib is a drug for the treatment of cancer, improved the condition of children with progeria. The study of its and other farnesyltransferase inhibitors will help to better understand the causes of diseases of the cardiovascular system and the mechanisms of normal aging.

27.09.2012
Other life sciences

Alzheimer's disease: an offensive on all fronts

September 2012 received the status of the first world Alzheimer's Disease month. In this regard, Professor Philippe Amuel, director of the DISTALZ program, answers questions from the correspondent of the Indian Express Pharma website.

27.09.2012
Your health

The nocebo effect

While the placebo effect, in which a patient's positive expectations can have a therapeutic effect, is relatively well known and studied, the nocebo effect is its little-known bad twin brother.

26.09.2012
Biomedicine

Keratin antibiotic?

Researchers from the University of California at Berkeley found small fragments of keratin proteins with powerful antimicrobial properties in the cornea of the human eye.

26.09.2012
Healthy skepticism

Harm of GM corn: the opinion of non-pseudo-scientists

The comments of the scientific community about the article on the oncogenic effect of genetically modified corn do not leave a stone unturned from the horror stories of French pseudoscientists.

26.09.2012